tirzepatide news october 18 2025 Medscape | The FDA approved Zepbound in December 2024 for the treatment of moderate-to-severe obstructive sleep apnea in patients with obesity after Lilly hikes revenue forecasts on

Still have questions or want examples of how people integrate Mounjaro into daily life

### US Regional Pricing Variations | Region | Compounded Monthly Cost | Telehealth Consultation | Notes | |--------|------------------------|------------------------|-------| | Northeast (NY, NJ, MA, CT) | $350-650 | $150-250 | Higher pharmacy costs | | Southeast (FL, GA, TX, NC) | $250-500 | $100-200 | More competitive pricing | | Midwest (IL, OH, MI, MN) | $280-520 | $100-175 | Moderate pricing | | West Coast (CA, WA, OR) | $300-600 | $150-250 | Premium market | | Mountain West (CO, AZ, UT) | $260-480 | $100-175 | Growing availability | ### How US Patients Access Retatrutide 1

Other nutrients that support serotonin and neurotransmitter balance may be helpful, too

Szilrd Kiss .